2.8 C
Thursday, June 13, 2024

Latest news: Pfizer

Australians abandon failed mRNA Covid shots

After climbing the world leaderboard during the initial Covid vaccine rollout to achieve over 95% vaccination coverage,¹ Australians have turned their back on boosters, with the vast majority now ‘under-vaccinated’.

Moderna sues Pfizer/BioNTech over COVID-19 vaccine

COVID-19 vaccine maker Moderna is suing Pfizer and BioNTech, accusing its main competitors of copying Moderna's technology in order to make their own vaccine.

CDC quietly changes advice on spacing COVID-19 jabs

Some people getting Pfizer or Moderna COVID-19 vaccines should consider waiting up to eight weeks between the first and second doses, instead of the three or four weeks previously recommended, US health officials say.

Pfizer pill ‘slashes risk of severe virus’

Pfizer's experimental antiviral pill to treat COVID-19 reportedly cuts by 89 per cent the chances of hospitalisation or death for adults at risk of developing severe disease.

ACT records 31 new cases, 17 infectious in the community

The ACT has recorded 31 new cases overnight, with 17 linked to existing cases or ongoing clusters and 17 in the community while infectious.

Barr lashes feds over Pfizer distribution

ACT Chief Minister Andrew Barr has lashed the federal government for not boosting Canberra's allocation of Pfizer vaccines.

Pfizer aplenty, angst over vaccine targets

Australians who have been holding off getting a coronavirus vaccination or waiting for a Pfizer jab will have no excuse in the coming weeks.

Record number of new COVID cases in Israel despite top jab rollout

Israel has announced nearly 11,000 new coronavirus cases in a day, a new record since the pandemic broke out - despite the country's world-leading vaccination campaign.

Children aged 12 to 15 now eligible to book Pfizer jab

Children aged between 12 and 15 years will be able to book a COVID-19 Pfizer jab from 13 September following the Commonwealth Government’s decision to implement expert medical advice.

Oxford study finds COVID-19 vaccine efficacy wanes

A British public health study has found protection from either of the two most commonly used COVID-19 vaccines against the Delta variant of the coronavirus weakens within three months.

Pfizer bookings open for ACT 30-39s

People aged between 30 and 39 in Canberra can now book in for their Pfizer COVID-19 vaccine at an ACT Government clinic.

Vulnerable children given Pfizer priority

Expert approval of the vaccination of all children aged 12 to 15 for COVID-19 could be given within weeks.

Under 40s still have to wait to access Pfizer

Adults under the age of 40 will still need to wait until September or October to access Pfizer vaccines.